(B) GST pull-down assays. E. coli lysates that expressed GST-Upf1 (ϩ) were mixed with E. coli lysates that did not (Ϫ) or did (ϩ) express 6xHis-Stau1, purified using glutathione-Sepharose beads (After) or not (Before), and subjected to Western blotting (WB) using ␣-GST antibody (upper) or ␣-His antibody (middle). Additionally, a fraction of each sample was analyzed by Coomassie blue staining to verify the presence of GST-Upf1 and 6xHis-Stau1 (lower, indicated by dots). (C) Far Western analysis. E. coli lysates that did not (Ϫ) or did (ϩ) produce either 6xHis-Stau1 or GST-Stau1 were subjected to Far Western blotting (FW) using FLAG-Upf1 that had been immunopurified from HeLa cells (middle) or GST-Upf1 that had been immunopurified from E. coli (right). Interacting proteins were identified by Western blotting using ␣-FLAG or ␣-GST antibody, respectively. Expression of 6xHis-Stau1 and GST-Stau1 was also verified by staining each lysate with Coomassie blue (left). (D) IP of Stau1-HA 3 . Cos cells were transiently transfected with a plasmid that expressed the 55 kDa isoform of Stau1-HA 3 . After cell lysis, RNA and protein were purified from the lysate before and after IP using ␣-HA antibody or, to control for the specificity of the IP, rat (r) IgG.
Here we show that mammalian Stau1 binds the NMD ure 1C, right). Coomassie blue staining confirmed the presence of 6xHis-Stau1 and GST-Stau1 ( Figure 1C , factor Upf1 and the 3Ј-untranslated region (UTR) of mRNA that encodes ADP-ribosylation factor (Arf)1. As left). Third, Stau1-HA 3 that had been immunopurified from a result, Stau1 mediates Arf1 mRNA decay by a mechanism that differs from NMD because it occurs indepenCos cells using ␣-HA antibody copurified with cellular Upf1 in a manner that was resistant to the addition of dently of splicing and after downregulating Upf2 or Upf3X but not after downregulating Stau1. Analogously RNase A prior to immunopurification (IP) ( Figure 1D , upper). This suggests that the interaction of Stau1 and to the SMD of Arf1 mRNA, artificially tethering Stau1 downstream of a normal termination codon also reduces Upf1 is stable in the absence of RNA. RNase A treatment was effective, as demonstrated by the disappearance mRNA abundance by a mechanism that depends on the normal termination codon and Upf1 but does not require of cellular SMG7 mRNA in samples that were analyzed before IP ( Figure 1D , lower). Stau1-HA 3 also coimmunosplicing and is unaffected when Upf2 or Upf3X is downregulated. Microarray analyses have identified a number purified with Barentsz and CBP80, although in an RNase A-sensitive manner, but did not coimmunopurify with of transcripts in addition to Arf1 mRNA that bind Stau1 and therefore may also be regulated by SMD. eIF4E or a nonspecific control, vimentin, which is a component of intermediate filaments ( Figure 1D, Figure 1A, lower) . unclear why ␣-Upf3/3X antibody failed to immmunopurThe ability of Upf1 to interact directly with Stau1 was ify Barentsz ( Figure 1E ). confirmed using copurification assays. First, GST-Upf1
Fourth, FLAG-Upf1 that had been isolated from HeLa that had been produced in E. coli interacted with 6xHis-cells using ␣-FLAG antibody that was covalently conjuStau1 that had also been produced in E. coli. This was gated to an agarose affinity gel (Pal et al., 2001 ) copurievident using GST pull-down to isolate GST-Upf1 ( 
Downregulating Cellular Stau1 Has No Detectable
Consequence to the EJC-Dependent NMD Second, FLAG-Upf1 that had been purified from HeLa cells as well as GST-Upf1 that had been purified from of Gl or GPx1 mRNA To gain insight into the possibility that Stau1 functions E. coli were shown by Far Western analysis to interact with 6xHis-Stau1 or GST-Stau1 that had been produced in EJC-dependent NMD, the effect of downregulating the level of cellular Stau1 on the NMD of mRNAs for in E. coli. To this end, each tagged Stau1 protein was electrophoresed in SDS-polyacrylamide and probed ␤-globin (Gl) and glutathione peroxidase (GPx)1 was examined using small interfering RNAs (siRNAs). As a conwith either FLAG-Upf1 followed by Western blotting using ␣-FLAG antibody ( Figure 1C, middle) or GST-Upf1 trol, Upf3X was downregulated in parallel. HeLa cells were transfected with Stau1 siRNA, Upf3X siRNA, or a followed by Western blotting using ␣-GST antibody ( (A-C) HeLa cells were transiently transfected with the specified siRNA. Two days later, cells were transfected with pcFLuc-MS2bs, pRLuc, and the specified effector plasmid. Alternatively, cells were transfected with a pmCMV-Gl test plasmid (either Norm or Ter) and the phCMV-MUP reference plasmid. After an additional 2 days, protein and RNA were purified. Western blotting was used to quantitate the extent of downregulation (left). RT-PCR was used to quantitate the effects of siRNA on Gl mRNA abundance (middle), as in Figure 2B , or FLuc-MS2bs mRNA abundance after tethering the specified protein (right), as in Figure 3B . For all RT-PCR results, mRNA levels in at least two independently performed experiments did not differ by more than 10%.
4A and 4B, right). We conclude that (1) Upf1 functions
In related experiments, the effect of downregulating the level of cellular Stau1 or, as a control, cellular Upf1 downstream of Stau1 in the Stau1-mediated reduction in mRNA abundance, and (2) Stau1 reduces mRNA on NMD that was elicited by tethering Upf1, Upf2, or Upf3 to FLuc mRNA was determined. The level of each abundance by a mechanism that does not appear to involve Upf2 or Upf3X. These results make sense, given Stau1 isoform was downregulated to 29% of normal, and the level of Upf1 was downregulated to 7% of northat Stau1 binds Upf1 (Figure 1 ) and that Upf1 is the last of the Upf proteins to function in EJC-dependent mal ( Figure 4C, left) . According to expectations, downregulating Upf1 abrogated NMD that was elicited by NMD (Lykke-Andersen et al., 2000) . tethering either Upf2 or Upf3 (Figure 4C, right) . In con-
The results of Western blotting demonstrated that the level of each Stau1 isoform was downregulated to 26% trast, however, downregulating Stau1 had no effect on of normal, and the level of Upf1, Upf2, or Upf3X was NMD that was elicited by tethering Upf1, Upf2, or Upf3 downregulated to, respectively, 21%, 22%, or 13% of ( Figure 4C, right that terminate at nucleotide 621 or 688 reflects our findthe 3ЈUTR downstream of nucleotide 919 or upstream of nucleotide 688, our finding that inserting the Stau1 ing that Stau1 binds less efficiently to the coding region than to the 3ЈUTR (Figures 5D and 6B ). While these data binding site (SBS, nucleotides 622-924) within FLuc mRNA reduced FLuc mRNA abundance (Supplemental do not rule out the possibility that Stau1 also binds within Figure S5A ) corroborates that Stau1 indeed binds be-S6). Consistent with these conclusions, we provide evidence that Upf1 is the last of the Upf proteins to function tween nucleotides 689 and 919. We conclude that Stau1 in EJC-dependent NMD and that Upf3 and Upf3X funcbinds to the 3ЈUTR of Arf1 mRNA at a position that is tion prior to Upf2 (Figure 4 ). predicted to reduce mRNA abundance.
We Figure 1) . or, as negative controls, mUpf2 siRNA or control siRNA As a rule, a termination codon that resides more than and, 2 days later, with the pfos-Arf1-SBS test plasmid ‫55-05ف‬ nt upstream of an exon-exon junction elicits and the phCMV-MUP reference plasmid in the absence NMD (Nagy and Maquat, 1998). Considering that an EJC of serum. One day later, serum was added, and protein resides ‫52-02ف‬ nt upstream of an exon-exon junction and RNA were purified from, respectively, cytoplasmic (Le Hir et al., 2000a), it follows that a termination codon and nuclear fractions after 0, 30, 60, 90, and 120 min.
that resides more than ‫52ف‬ nt upstream of a Stau1 Western blotting demonstrated that the levels of binding site should elicit SMD. These two scenarios are mStau1, mUpf1, and mUpf2 were downregulated to, reexemplified for Arf1 mRNA, which harbors four exonspectively, 21%, 18%, and 26% of normal ( Figure 6C , exon junctions and binds Stau1 Ն67 nt downstream of second from top, left and right). RT-PCR demonstrated the normal termination codon (Figure 7 ). In theory, it that downregulating mStau1 or mUpf1 increased the may be possible for a termination codon to be situated half-life of nucleus-associated fos-Arf1-SBS mRNA, so that it elicits both EJC-independent SMD and EJCwhereas downregulating mUpf2 did not ( Figure 6C , secdependent NMD. In fact, our data indicate that this posond from bottom, and bottom, left and right). These data sibility exists for Arf1 mRNA, which is normally a product reveal that Stau1 together with Upf1 mediates the decay of pre-mRNA splicing and binds Stau1 within its codof Arf1 mRNA, which we call Stau1-mediated mRNA ing region.
decay (SMD). The specificity of the SBS involvement in
We have found in two independently performed mi-SMD was evident with the finding that downregulating croarray analyses that there are at least 22 293 cell mStau1 to 29% of normal also increased the half-life of mRNAs in addition to Arf1 mRNA that bind Stau1 (Supfos-FLuc-SBS mRNA (Supplemental Figure S5B) . Furplemental Table S1 ). This suggests that SMD is used thermore, downregulating mStau1 to a comparable level by cells to coordinately regulate a battery of genes in (21% of normal) had no effect on the half-life of fosresponse to changes in the cellular abundance or speArf1⌬(3ЈUTR) mRNA (Supplemental Figure S6) . These cific activity of Stau1, Upf1, or both (see below). If binddata, like the steady-state data (Figures 4 and 5 and ing is sufficiently downstream of the normal termination Supplemental Figures S4 and S5A) , indicate that the codon, then these mRNAs should, like Arf1 mRNA, be SMD of Arf1 mRNA involves the Arf1 SBS, Stau1, and natural targets of SMD by a mechanism that is EJC Upf1 but not detectably Upf2.
independent. For example, Stau1 also binds the 3ЈUTR of PAICS mRNA (and also elsewhere within PAICS Discussion mRNA), and downregulating Stau1 increases PAICS mRNA abundance ‫-2ف‬fold (Supplemental Figure S7) . In this communication, we describe a role for mammaNatural substrates for SMD could arise when a terminalian Stau1 in a type of mRNA decay that involves the tion codon is generated by alternative splicing, which NMD factor Upf1 but not an EJC. We demonstrate that has been proposed to occur one-third of the time (HillStau1 directly binds Upf1 (Figure 1) . We also demonman et al., 2004), provided that the termination codon strate that tethering Stau1 downstream of a termination resides a sufficient distance upstream of a Stau1 binding codon reduces mRNA abundance (Figure 3 ) by a mechasite. Notably, there may be mRNAs that are more effinism that appears to involve the termination codon (Supciently targeted for SMD than those identified to date, plemental Figure S2 ) and Upf1 but not detectably Upf2 i.e., that would have insufficient abundance to be deor Upf3X (Figure 4) . As additional support for the importected in a microarray analysis of Stau1 bound trantance of a termination codon, downregulating Stau1 inscripts (Supplemental Table S1 ). In fact, some of these creased the level of Arf1 35Ter mRNA that derived from may be among the mRNAs that increase in abundance cDNA (Y. Table S1 ).
al., 2001). In summary, our findings expand the role of Stau1 in Arf1 is involved in protein trafficking, and it may modulate vesicle budding and uncoating within the Golgi apposttranscriptional gene control. Significant issues that have been brought to light by our studies include whether paratus. PAICS controls steps 6 and 7 of the purine nucleotide biosynthetic pathway. Interestingly, the level the Stau1-mediated recruitment of Upf1 to mRNAs impacts mammalian development, neuronal transmission, of PAICS mRNA varies with the cell cycle in synchronized rat 3Y1 fibroblasts (Iwahana et al., 1995) . At least or cellular growth control. It will also be important to determine if Staufen and Upf1 interact in Drosophila so in theory, this variation may be controlled by SMD. From these and other examples, it is conceivable that modulaas to elicit mRNA decay. tion of Stau1, Upf1, or both may control the level of SMD Experimental Procedures in response to signal transduction or other regulatory pathways.
Plasmid Constructions
In addition to its involvement in this type of mRNA 
